Nephrology Late Breakers (2025)

Learning Objectives:

  • Understand role of GLP1 drugs in diabetic nephropathy
  • Become aware of alternative targets for HTN therapeutics
  • Understand current recommendations for sodium correction

John E. Prior, DO, FACOI

Nephrologist

NEPA Nephrology Associates

Clinical instructor Wright Center for Graduate Medical Education

The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose. 

Key:

Complete
Failed
Available
Locked
Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Webcast
04/24/2025 at 1:25 PM (EDT)  |  Recorded On: 04/24/2025  |  23 minutes
04/24/2025 at 1:25 PM (EDT)  |  Recorded On: 04/24/2025  |  23 minutes
Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Evaluation
17 Questions